Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Bronchial Tissue Immune Activation Seen in Early Rheumatoid Arthritis

Reuters Staff  |  November 17, 2015

NEW YORK (Reuters Health)—Patients with untreated early rheumatoid arthritis (RA) show signs of immune activation and local inflammation in their bronchial tissues, researchers from Sweden report.

Previous studies have shown that patients with RA have shared citrullinated epitopes in the lungs and joints, as well as anticitrullinated protein antibodies (ACPA) in bronchoalveolar lavage (BAL), suggesting that RA-associated autoimmunity could begin in the lung compartment.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Anca I. Catrina and colleagues from Karolinska Institute, Stockholm, sought to characterize lymphocytic infiltration in the large and small airways of 24 patients with early, untreated RA without clinical lung disease as part of the LUng investigations in early RA (LURA) study.

ACPA-positive patients had evidence of airflow limitations and decreased gas transfer, compared with ACPA-negative patients. ACPA-positive patients were also more likely than other RA patients to have evidence on high-resolution computed tomography (CT) of parenchymal and airway changes.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Bronchial biopsies showed frequent lymphocytic infiltration, along with expression of immune activation markers, especially in ACPA-positive patients, according to the Nov. 3 Annals of the Rheumatic Diseases online report.

Compared with controls, ACPA-positive (but not ACPA-negative) patients had increased numbers of B and T lymphocytes and reduced numbers of macrophages in BAL fluid.

“The possibility that early changes (such as the ones described here) might also to a certain extent be due to a direct antibody-mediated injury and/or low-grade inflammation already before disease onset cannot be completely excluded,” the researchers note. “Isolation of ACPA-producing B cells from the lung compartment would be the final proof of local immune activation and antibody production, and this still remains to be done.”

“In conclusion, we have demonstrated signs of immune activation in BAL and bronchial biopsies of patients with early untreated ACPA-positive RA,” they write. “This strengthens the hypothesis that the lung plays an important role in the immunological reactions responsible for the development of ACPA-positive RA, and warrants further functional and interventional studies to address this pathogenic link.”

Dr. Catrina did not respond to a request for comment.

This research had multiple supporters. The authors reported no disclosures.

Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:ACPAanti-citrullinated protein antibodiesinflammationlungRheumatoid Arthritis (RA)

Related Articles

    ACPA-Positive & ACPA-Negative Patients with RA: The Difference Begins in the Lungs

    January 4, 2016

    A new study from Stockholm, Sweden, strengthens the link between the lungs and anti-citrullinated protein antibody (ACPA)–positive RA. After analyzing the bronchial tissue of untreated patients with early RA, researchers found the patients’ lungs had signs of immune cell accumulation and activation…

    2013 ACR/ARHP Annual Meeting: Research Provides Insight into Preclinical Rheumatic Disease

    February 1, 2014

    Data offer clues to role of mucosal biology in etiology of rheumatoid arthrits and early pathology of rheumatic diseases

    Plasma Cells, Synovial Compartment Implicated in Tenacity of Rheumatoid Arthritis

    October 10, 2016

    LONDON—New research shows that the synovial compartment appears to have a special role in the chronic nature of rheumatoid arthritis (RA), providing refuge for plasma cells and giving them an ideal environment in which to produce antibodies against citrullinated protein antigens (ACPA). The findings were presented at the Annual Congress of the European League Against…

    Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention

    Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention

    October 11, 2016

    Established wisdom holds that patients with rheumatoid arthritis (RA) will fare better if their disease is diagnosed as early as possible, and treatments with disease-modifying drugs are started before inflammation can do more damage to joints and tissue. Usually, early diagnosis means spotting the clinical signs of disease, but new research tells us more about…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences